Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro de Estudos e Pesquisas em Moléstias Infecciosas (CEPMI) is a specialized clinical research center located in Santos, Brazil, dedicated to the study and treatment of infectious diseases. The center serves as a key site for international and multicenter clinical trials, focusing on therapeutic areas such as HIV/AIDS, viral hepatitis, and emerging viral infections like COVID-19. CEPMI provides comprehensive clinical research services, including patient recruitment, trial management, and data collection, adhering to Good Clinical Practice (GCP) standards. By collaborating with global pharmaceutical companies and research organizations, the center contributes significantly to the development of new vaccines and antimicrobial therapies. Its infrastructure is specifically designed to support Phase II, III, and IV clinical investigations within the Latin American region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro de Estudos e Pesquisas em Moléstias Infecciosas.